NanoViricides Inc. (NNVC)

[freethemice]

You keep saying that Sangamo has huge potential. So far I just see their technology
as being applied to diseases which result from a change in a single gene.
That makes it a niche market for niche diseases. Most diseases (like cancer)
result from changes to many, many genes. Those genes also do many other things,
so if you change them there will likely be many unanticipated side effects.
Even the treatment for HIV doesn't seem feasible for practical reasons.